The Oncology Institute, Inc. TOI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$43.51M+32.4% | -$60.61M+6.3% | -$66.28M+5.6% | -$65.89M+7.9% | -$64.36M+11.8% | ||
| $6.78M+2.9% | $6.94M+10.5% | $7.02M+14.0% | $6.87M+9.3% | $6.58M+8.0% | ||
| $4.78M-43.9% | $4.55M-59.2% | $4.52M-67.6% | $5.89M-63.7% | $8.52M-49.7% | ||
| $4.72M-51.0% | $8.38M+32.9% | $8.77M+39.6% | $9.18M+46.7% | $9.62M+54.1% | ||
| $11.1M— | $12.95M— | —— | —— | —— | ||
| —— | —— | $8.78M+518% | $4.46M+608% | $754K-40.5% | ||
| $19.19M— | $19.64M— | $12.67M— | $19.81M— | —— | ||
| $903K— | -$448K— | $7.05M— | $9.76M— | —— | ||
| $29K+26.1% | $17K-39.3% | -$2K-107% | $4K-84.0% | $23K-43.9% | ||
| —— | —— | —— | -$134K+53.8% | -$121K+85.6% | ||
| -$3.26M— | -$2.03M— | -$2.99M— | —— | —— | ||
| -$518K— | -$494K— | —— | —— | —— | ||
| $1.29M+4,383% | $291K+237% | $279K— | $216K— | -$30K— | ||
| —— | —— | -$23.82M+32.8% | -$11.19M+74.4% | -$16.65M+54.7% | ||
| $3.91M— | $3.2M— | $3.9M— | —— | —— | ||
| —— | —— | —— | —— | $126K— | ||
| -$3.91M-114% | -$3.07M-106% | -$2.01M-103% | $8.99M-84.2% | $28.38M-55.4% | ||
| —— | —— | —— | —— | $20M— | ||
| $13.73M+21,345% | $13.84M— | $9.95M+8,707% | $2.27M+1,027% | $64K-67.8% | ||
| $36K-10.0% | $37K-5.1% | $38K-2.6% | $41K+7.9% | $40K-56.5% | ||
| $16.27M+323% | $11.56M+431% | $7.66M+250% | -$3.18M+43.4% | -$7.29M-20.0% | ||
| —— | —— | -$19.74M-199% | -$6.13M-169% | $3.68M-83.4% | ||
| $3.51M-24.5% | $3.91M-13.0% | $4.2M-5.9% | $4.43M-1.0% | $4.65M+3.1% | ||
| $4.72M-51.0% | $8.38M+32.9% | $8.77M+39.6% | $9.18M+46.7% | $9.62M+54.1% | ||
| -$4.97M-712% | -$13.27M-592% | -$13.14M— | -$7.17M— | -$612K— | ||
| -$518K— | -$494K— | —— | —— | —— | ||
| —— | —— | —— | -$134K+53.8% | -$121K+85.6% | ||
| $1.29M+4,383% | $291K+237% | $279K— | $216K— | -$30K— | ||
| -$3.26M— | -$2.03M— | -$2.99M— | —— | —— | ||
| —— | —— | —— | —— | $126K— | ||
| $36K-10.0% | $37K-5.1% | $38K-2.6% | $41K+7.9% | $40K-56.5% | ||
| $1.03M— | $991K— | $845K— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $15.36M— | ||
| —— | —— | —— | —— | $4.11M— | ||
| $36K+106% | $247K+140% | $199K+187% | $29K+680% | -$576K-234% | ||
| -$518K— | -$494K— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.38M+47.3% | ||
| —— | —— | —— | —— | —— | ||
| -$27.9M— | -$29.96M— | —— | —— | —— | ||
| -$27.9M— | -$29.96M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does The Oncology Institute, Inc. generate?
- The Oncology Institute, Inc. (TOI) generated -$30.0M in operating cash flow over the trailing twelve months.
- What is The Oncology Institute, Inc.'s free cash flow?
- After $3.9M of capital expenditures, The Oncology Institute, Inc.'s free cash flow was -$27.9M over the trailing twelve months, up 36.7% year over year.
- Where does The Oncology Institute, Inc.'s cash flow data come from?
- Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
